These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

183 related items for PubMed ID: 4019742

  • 21. [Phenotypic and genotypic characteristics of non fermenting atypical strains recovered from cystic fibrosis patients].
    Ferroni A, Sermet-Gaudelus I, Abachin E, Quesnes G, Lenoir G, Berche P, Gaillard JL.
    Pathol Biol (Paris); 2003 Sep; 51(7):405-11. PubMed ID: 12948761
    [Abstract] [Full Text] [Related]

  • 22. Differences in drug susceptibility between isolates of Pseudomonas cepacia recovered from patients with cystic fibrosis and other sources and its relationship to beta-lactamase focusing pattern.
    Aronoff SC, Labrozzi PH.
    Pediatr Pulmonol; 1986 Sep; 2(6):368-72. PubMed ID: 3492701
    [Abstract] [Full Text] [Related]

  • 23. A novel chromogenic medium for isolation of Pseudomonas aeruginosa from the sputa of cystic fibrosis patients.
    Laine L, Perry JD, Lee J, Oliver M, James AL, De La Foata C, Halimi D, Orenga S, Galloway A, Gould FK.
    J Cyst Fibros; 2009 Mar; 8(2):143-9. PubMed ID: 19097827
    [Abstract] [Full Text] [Related]

  • 24. Improved recovery of mycobacteria from respiratory secretions of patients with cystic fibrosis.
    Whittier S, Hopfer RL, Knowles MR, Gilligan PH.
    J Clin Microbiol; 1993 Apr; 31(4):861-4. PubMed ID: 8463398
    [Abstract] [Full Text] [Related]

  • 25. Auxotrophy of Burkholderia (Pseudomonas) cepacia from cystic fibrosis patients.
    Barth AL, Pitt TL.
    J Clin Microbiol; 1995 Aug; 33(8):2192-4. PubMed ID: 7559977
    [Abstract] [Full Text] [Related]

  • 26. [Isolation frequency of Burkholderia cepacia from cystic fibrosis patients].
    Ocak F, Gözalan A, Ozçelik U, Anadol D, Kiper N, Aktepe OC, Göçmen A, Esen B.
    Mikrobiyol Bul; 2002 Jan; 36(1):1-10. PubMed ID: 12476760
    [Abstract] [Full Text] [Related]

  • 27. Binding of Pseudomonas cepacia to normal human intestinal mucin and respiratory mucin from patients with cystic fibrosis.
    Sajjan US, Corey M, Karmali MA, Forstner JF.
    J Clin Invest; 1992 Feb; 89(2):648-56. PubMed ID: 1371125
    [Abstract] [Full Text] [Related]

  • 28. Cultures of thoracotomy specimens confirm usefulness of sputum cultures in cystic fibrosis.
    Thomassen MJ, Klinger JD, Badger SJ, van Heeckeren DW, Stern RC.
    J Pediatr; 1984 Mar; 104(3):352-6. PubMed ID: 6423790
    [Abstract] [Full Text] [Related]

  • 29. Utilization of human respiratory secretions by mucoid Pseudomonas aeruginosa of cystic fibrosis origin.
    Ohman DE, Chakrabarty AM.
    Infect Immun; 1982 Aug; 37(2):662-9. PubMed ID: 6811437
    [Abstract] [Full Text] [Related]

  • 30. Microbiologic data overview of Italian cystic fibrosis patients.
    Taccetti G, Campana S.
    Eur J Epidemiol; 1997 Apr; 13(3):323-7. PubMed ID: 9258532
    [Abstract] [Full Text] [Related]

  • 31. Selective medium for Pseudomonas cepacia containing 9-chloro-9-(4-diethylaminophenyl)-10-phenylacridan and polymyxin B sulfate.
    Wu BJ, Thompson ST.
    Appl Environ Microbiol; 1984 Oct; 48(4):743-6. PubMed ID: 6095757
    [Abstract] [Full Text] [Related]

  • 32. [Use of 16S rRNA gene sequencing for identification of "Pseudomonas-like" isolates from sputum of patients with cystic fibrosis].
    Moissenet D, Bingen E, Arlet G, Vu-Thien H.
    Pathol Biol (Paris); 2005 Oct; 53(8-9):500-2. PubMed ID: 16081224
    [Abstract] [Full Text] [Related]

  • 33. Pseudomonas cepacia in the sputum of cystic fibrosis patients.
    Taylor PC, Kalamatianos CC.
    Pathology; 1994 Jul; 26(3):315-7. PubMed ID: 7527513
    [Abstract] [Full Text] [Related]

  • 34. Pseudomonas cepacia in the hospital setting: lack of transmission between cystic fibrosis patients.
    Hardy KA, McGowan KL, Fisher MC, Schidlow DV.
    J Pediatr; 1986 Jul; 109(1):51-4. PubMed ID: 3723240
    [Abstract] [Full Text] [Related]

  • 35. Polymerase chain reaction for the detection of Pseudomonas aeruginosa, Stenotrophomonas maltophilia and Burkholderia cepacia in sputum of patients with cystic fibrosis.
    Karpati F, Jonasson J.
    Mol Cell Probes; 1996 Dec; 10(6):397-403. PubMed ID: 9025076
    [Abstract] [Full Text] [Related]

  • 36. Misidentification of Burkholderia cepacia in US cystic fibrosis treatment centers: an analysis of 1,051 recent sputum isolates.
    McMenamin JD, Zaccone TM, Coenye T, Vandamme P, LiPuma JJ.
    Chest; 2000 Jun; 117(6):1661-5. PubMed ID: 10858399
    [Abstract] [Full Text] [Related]

  • 37. Xanthomonas maltophilia misidentified as Pseudomonas cepacia in cultures of sputum from patients with cystic fibrosis: a diagnostic pitfall with major clinical implications.
    Burdge DR, Noble MA, Campbell ME, Krell VL, Speert DP.
    Clin Infect Dis; 1995 Feb; 20(2):445-8. PubMed ID: 7537977
    [Abstract] [Full Text] [Related]

  • 38. Evaluation of RGM Medium for Isolation of Nontuberculous Mycobacteria from Respiratory Samples from Patients with Cystic Fibrosis in the United States.
    Plongla R, Preece CL, Perry JD, Gilligan PH.
    J Clin Microbiol; 2017 May; 55(5):1469-1477. PubMed ID: 28228494
    [Abstract] [Full Text] [Related]

  • 39. Membrane phospholipid composition of Pseudomonas aeruginosa grown in a cystic fibrosis mucus-mimicking medium.
    Deschamps E, Schaumann A, Schmitz-Afonso I, Afonso C, Dé E, Loutelier-Bourhis C, Alexandre S.
    Biochim Biophys Acta Biomembr; 2021 Jan 01; 1863(1):183482. PubMed ID: 33002450
    [Abstract] [Full Text] [Related]

  • 40. Colonization of the respiratory tract with Pseudomonas cepacia in cystic fibrosis. Risk factors and outcomes.
    Tablan OC, Martone WJ, Doershuk CF, Stern RC, Thomassen MJ, Klinger JD, White JW, Carson LA, Jarvis WR.
    Chest; 1987 Apr 01; 91(4):527-32. PubMed ID: 3829745
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 10.